Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular DeliveryChicoine, LG ; Montgomery, CL ; Bremer, WG ; Shontz, KM ; Griffin, DA ; Heller, KN ; Lewis, S ; Malik, V ; Grose, WE ; Shilling, CJ ; Campbell, KJ ; Preston, TJ ; Coley, BD ; Martin, PT ; Walker, CM ; Clark, KR ; Sahenk, Z ; Mendell, JR ; Rodino-Klapac, LRMolecular therapy, 2014-02, Vol.22 (2), p.338-347 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
|
2 |
Material Type: Artigo
|
FDA-regulated research: cellular therapy considerationsBosse, K ; Watts, M.C ; Shilling, C ; Jewell, L ; O'Donnell, L ; Lee, D.ACytotherapy (Oxford, England), 2019-05, Vol.21 (5), p.S44-S44 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
3 |
Material Type: Artigo
|
Physical capital and situated action:a new direction for corporeal sociologyShilling, ChrisBritish journal of sociology of education, 2004-09, Vol.25 (4), p.473-487 [Periódico revisado por pares]Oxford: Taylor & Francis LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
Tertiary Structure and Characterization of a Glycoside Hydrolase Family 44 Endoglucanase from Clostridium acetobutylicumWarner, Christopher D ; Hoy, Julie A ; Shilling, Taran C ; Linnen, Michael J ; Ginder, Nathaniel D ; Ford, Clark F ; Honzatko, Richard B ; Reilly, Peter JApplied and Environmental Microbiology, 2010-01, Vol.76 (1), p.338-346 [Periódico revisado por pares]Washington, DC: American Society for MicrobiologyTexto completo disponível |
|
5 |
Material Type: Artigo
|
G.O.24Mendell, J.R ; Rodino-Klapac, L ; Sahenk, Z ; Roush, K ; Bird, L ; Lowes, L.P ; Alfano, L ; Gomez, A.M ; Lewis, S ; Malik, V ; Shontz, K ; Flanigan, K.M ; Shilling, C ; Sazani, P ; Saoud, J ; Duda, P ; Kaye, ENeuromuscular disorders : NMD, 2014-10, Vol.24 (9), p.922-922 [Periódico revisado por pares]Texto completo disponível |
|
6 |
Material Type: Artigo
|
PP09.16 – 2691: Eteplirsen, a phosphorodiamidate morpholino oligomer (PMO) for the treatment of Duchenne muscular dystrophy (DMD): 3.2 year update on six-minute walk test (6MWT), pulmonary function testing (PFT), and safetyKaye, E.M ; Mendell, J.R ; Rodino-Klapac, L ; Sahenk, Z ; Roush, K ; Lowes, L.P ; Alfano, L ; Gomez, A.M ; Malik, V ; Flanigan, K.M ; Shilling, C ; Duda, P ; Saoud, JEuropean journal of paediatric neurology, 2015-05, Vol.19, p.S69-S69 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
G.P.110Sazani, P ; Magee, T ; Charleston, J.S ; Shanks, C ; Zhang, J ; Carver, M ; Rodino-Klapac, L ; Sahenk, Z ; Roush, K ; Bird, L ; Lowes, L.P ; Alfano, L ; Gomez, A.M ; Lewis, S ; Malik, V ; Shontz, K ; Flanigan, K ; Shilling, C ; Bhalli, J ; Kaur, H ; Walisser, J ; Forget, J ; Saoud, J ; Mendell, J.R ; Kaye, ENeuromuscular disorders : NMD, 2014-10, Vol.24 (9), p.828-828 [Periódico revisado por pares]Texto completo disponível |
|
8 |
Material Type: Artigo
|
Culture, the 'sick role' and the consumption of healthShilling, ChrisThe British journal of sociology, 2002-12, Vol.53 (4), p.621-638 [Periódico revisado por pares]Oxford, UK: Blackwell PublishingTexto completo disponível |
|
9 |
Material Type: Artigo
|
Penile cancer in younger men – a more aggressive disease?O'Kelly, J. ; Browne, E. ; Daly, P. ; Shah, N. ; Shilling, C. ; Cullen, I.MEuropean urology, 2022-02, Vol.81, p.S1025-S1026 [Periódico revisado por pares]Texto completo disponível |
|
10 |
Material Type: Artigo
|
P.11.20 Results at 2 years of a phase IIb extension study of the exon-skipping drug eteplirsen in patients with DMDMendell, J.R ; Rodino-Klapac, L ; Sahenk, Z ; Roush, K ; Bird, L ; Lowes, L.P ; Alfano, L ; Gomez, A.M ; Lewis, S ; Malik, V ; Shontz, K ; Flanigan, K.M ; Kean, J.R ; Allen, H.D ; Shilling, C ; Sazani, P ; Saoud, J ; Kaye, E.MNeuromuscular disorders : NMD, 2013-10, Vol.23 (9), p.804-805 [Periódico revisado por pares]Elsevier B.VTexto completo disponível |